E

Sailing into the IO headwind

Figuring out how to combine different IO approaches will take time so what have we learned lately?

March 7, 2019
E

Sorting signals from the noise

PARP plus IO and IO combos are becoming all the rage, what can we learn from early signals?

March 5, 2019
E

How Will Adoptive Cell Therapy Crack Solid Tumours?

A look at Dr Malcolm Brenner's work on virus specific T cell therapies

January 31, 2018
E

Report on key data in GU Cancers from ASCO-SITC 2018

At ASCO-SITC this weekend there was some compelling new scientific data highlighting subsets of patients who might be eligible for cancer immunotherapy, including novel combination approaches.

January 30, 2018
E

Important ASCO-SITC 2017 Highlights and Trends

6 key trends and highlights of note from the inaugural ASCO-SITC meeting in Orlando, Florida

March 3, 2017
E

Novel Way to Improve Checkpoint Inhibitor Efficacy

A look at another surprising factor that might affect efficacy of cancer immunotherapy and checkpoint blockade.

March 1, 2017
E

A novel immune checkpoint target

After JAK1/2 upregulation and PTEN loss, a third mechanism of resistance to checkpoint blockade has been identified. We discuss the issues around this latest challenge...

February 28, 2017